George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksELTA.L Regulatory News (ELTA)

  • There is currently no data for ELTA

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Electra Private Equity plc

29 May 2018 13:00

RNS Number : 4262P
BlackRock Group
29 May 2018
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

 

1. KEY INFORMATION

 

(a) Full name of discloser:

BlackRock, Inc.

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Electra Private Equity plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

25 May 2018

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

25p ordinary

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

563,930

1.47%

0

0.00%

(2) Cash-settled derivatives:

 

207,492

0.54%

0

0.00%

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

0

0.00%

0

0.00%

 

TOTAL:

771,422

2.01%

0

0.00%

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

25p ordinary

Purchase

488

GBP 9.1000

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None.

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None.

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

No

 

Date of disclosure:

28 May 2018

Contact name:

Jana Blumenstein

Telephone number:

+44 20 7743 3650

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RETFKFDDDBKDOPB
Date   Source Headline
16th Jun 20217:00 amRNSTrading update and company announcement
14th Jun 202110:58 amRNSHalf-year Report
1st Jun 20218:00 amRNSTotal Voting Rights
28th May 202110:39 amRNSAnalyst Note produced by HSBC Global Research
26th May 202110:01 amRNSEdison issues update on Electra Private Equity
24th May 20212:26 pmRNSReplacement: Holding(s) in Company
24th May 20211:41 pmRNSHolding(s) in Company
24th May 20211:27 pmRNSDirector/PDMR Shareholding
24th May 20211:27 pmRNSDirector/PDMR Shareholding
24th May 20217:00 amRNSIssue of Equity
21st May 20211:00 pmRNS2021 Half Year Report Supplementary Information
21st May 20217:00 amRNSHalf-year Report
19th Apr 20217:00 amRNSEdison issues update on Electra Private Equity
15th Apr 20217:00 amRNSDisposal of Sentinel and Portfolio Trading Update
13th Apr 20214:41 pmRNSSecond Price Monitoring Extn
13th Apr 20214:35 pmRNSPrice Monitoring Extension
22nd Mar 20213:07 pmRNSHolding(s) in Company
19th Mar 20214:41 pmRNSSecond Price Monitoring Extn
19th Mar 20214:35 pmRNSPrice Monitoring Extension
5th Mar 20214:49 pmRNSDirector/PDMR Shareholding
4th Mar 20215:03 pmRNSDirector/PDMR Shareholding
4th Mar 202110:39 amRNSAGM Statement
3rd Mar 20215:21 pmRNSDirector/PDMR Shareholding
24th Feb 20214:45 pmRNSResult of AGM
24th Feb 20217:00 amRNSAGM Statement
26th Jan 20213:10 pmRNSAnnual Report and Notice of Annual General Meeting
17th Dec 20204:41 pmRNSEdison initiates on Electra Private Equity (ELTA)
17th Dec 20208:51 amEQSElectra Private Equity (ELTA): Innovating, restructuring and realising
16th Dec 202012:10 pmRNSEdison Investment Research note
9th Dec 20207:00 amRNSFinal Results
27th Nov 20204:41 pmRNSSecond Price Monitoring Extn
27th Nov 20204:36 pmRNSPrice Monitoring Extension
13th Nov 202010:33 amRNSPress speculation re Hotter Shoes
27th Aug 202011:37 amRNSConfirmation of Reduction of Capital
27th Aug 20207:00 amRNSExpiry of Hotter Shoes CVA Challenge Period
26th Aug 20209:08 amRNSHolding(s) in Company
29th Jul 202011:29 amRNSDirector/PDMR Shareholding
29th Jul 20207:00 amRNSCompany update including outcome of Hotter CVA
19th Jun 20202:41 pmRNSHotter Shoes Restructure
19th Jun 20201:33 pmRNSResult of General Meeting
12th Jun 20202:44 pmRNSHalf-year Report
22nd May 20205:02 pmRNSDirector/PDMR Shareholding
21st May 20207:00 amRNSNotice of General Meeting re reduction of capital
21st May 20207:00 amRNSHalf-year Report
1st May 20202:14 pmRNSDisclosure of rights attached to equity shares
20th Mar 20207:00 amRNSUpdate in respect of the COVID-19 situation
18th Mar 20204:43 pmRNSSecond Price Monitoring Extn
18th Mar 20204:39 pmRNSPrice Monitoring Extension
17th Mar 202011:47 amRNSHolding(s) in Company
16th Mar 202012:07 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.